Safety study of IBI3042 in healthy adults
This study tests a new experimental medicine called IBI3042, given as a single dose, to see how safe it is in healthy volunteers. It is an early-phase trial that helps doctors understand if the drug is well-tolerated before testing it in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You weigh at least 110 pounds and have a body mass index (BMI) between 20 and 32.
- You have never had diabetes or unusual blood sugar levels.
- You have no history of pancreas problems (like pancreatitis) or certain thyroid cancers.
- You are not taking any medications, supplements, or herbal products that could affect your stomach or blood sugar.
- If you are able to have children, you agree to use highly effective birth control during the study and for 90 days after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called IBI3032 in healthy volunteers to see how safe it is and how the body processes it. If you are in good health, you may be able to join.
This study tests an experimental drug called IBI3042 in healthy people who are normal weight, overweight, or obese. It is an early-stage trial looking at how safe and tolerable the drug is, and how it affects the body, which could eventually lead to a treatment for weight loss.
This is an early-stage safety study of a new drug called IBI3035 in healthy adult volunteers. Researchers want to understand how the drug is absorbed and processed by the body, and whether it causes any side effects.
This study tests a new drug called BIIB145 in healthy volunteers to see if it's safe and how the body handles it. It helps researchers learn about the drug before testing it in people with specific conditions.
This study tests an investigational drug called IBI3040 in healthy adults and in adults who are overweight or obese. It aims to see how the drug affects the body, which may help with weight management. Participants will be monitored closely throughout the study.
This trial tests a single dose of an experimental drug (BIIB144) in healthy adults to see if it is safe and how the body handles it. You would receive either the drug or a placebo (inactive shot) and be closely monitored.
Hear when a new Healthy Volunteers (HV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.